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ILLNESS IMPACT AND ADJUSTMENT TO PARKINSON'S DISEASE: 
BEFORE AND AFTER TREATMENT WITH TOLCAPONE 
There is evidence that adjustment to chronic illnesses 
such as Parkinson's disease (PD) may be affected by 
psychological factors especially how patients appraise and 
cope with the stress of their illness. There has been 
limited research available examining the role of illness 
impact or appraisal in adjustment to chronic illness. No 
studies were found dealing with the inter-relationship of 
illness impact, adjustment and pharmacological treatment.
The purpose of this study was to determine whether the 
quality of life (as conceptualized by impact of illness and 
adjustment) was improved by treatment with tolcapone in 
persons with Parkinson's disease. This study was done in 
parallel with a double-blind placebo controlled study of the 
efficacy and safety of tolcapone.
Quality of life was measured by the Sickness Impact 
Profile (SIP) and adjustment to Parkinson's disease by the 
Psychosocial Adjustment to Illness Scale (PAIS-SR).
Illness impact and adjustment to Parkinson's disease 
were improved across all treatment groups when compared to
iv
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patients who received placebo. Total illness impact was 
significantly improved (p = .003), physical illness impact 
was significantly improved (p = .05) and psychosocial 
illness impact was significantly improved (p = .007) in 
patients who received tolcapone when compared to placebo.
Adjustment to illness was not significantly different 
in the tolcapone group when compared to patients receiving 
placebo, however a dose related improvement response was 
found.
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CHAPTER I 
INTRODUCTION
Parkinson's Disease (PD), a chronic, degenerative, 
neurologic condition affects approximately 1% of the aged 
population. Parkinson's Disease is characterized by loss of 
neurons in the substantia nigra and other pigmented nuclei 
(Langston, Roller and Giron, 1992). Death of these 
specialized cells results in striatal dopamine deficiency, 
the primary neurochemical lesion of PD. Symptoms of 
idiopathic PD, the most common of the akinetic-rigid 
syndromes, include tremor, poverty of movement (akinesia), 
slowness and fatiguing (bradykinesia), postural instability 
and rigidity (Weiner and Lang, 1989) .
The complexity of motor dysfunction characteristic of 
Parkinson's Disease results in diminution of many aspects of 
movement. These impairments have far reaching consequences 
which affect independent activities of daily living, 
employment, role fulfillment, self concept and a myriad of 
interpersonal interactions. The decline in functional
1
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ability in PD can change robust and strong individuals into 
stooped and frail ones. PD can change confident and 
independent persons into depressed and dependent ones, or 
persons who were bright and alert can become apathetic and 
listless. The social burden of Parkinson's Disease symptoms 
is a heavy one. For the individual with this diagnosis, life 
is fraught with frustration, embarrassment and loneliness 
(Koller, 1987). Because of its progressive nature, PD 
eventually results in varying degrees of loss of an 
individual's independent functional ability. Adjustment to 
such changes presents the patient and family with enormous 
challenges.
The unique manner in which individuals and families 
deal with the demands of this progressive illness influences 
the degree and nature of lifelong adjustment and well-being. 
Though it is not possible to reverse the physical changes 
resulting from Parkinson's Disease, cognitive appraisal of 
the threat and personal resources may help to moderate the 
impact of the illness (Miller, 1992). Coping with the 
everyday problems that face individuals with Parkinson's 
Disease may be the greatest challenge (Hutton & Dipel,
1989) .
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Effective coping strategies utilized by individuals 
with Parkinson's Disease are critical to successful 
adjustment to this disabling disease. Learning to cope with 
an illness such as Parkinson's Disease requires great 
determination and a positive attitude (Crary & Waters,
1989) . Coping however may be linked to the individuals 
cognitive appraisal of the illness as a threat. Little is 
known about Parkinson patients' appraisal of this diagnosis 
as a threat or the impact this diagnosis and its'symptoms 
have on the individual or their families' functioning.
We are largely ignorant of how patients see themselves 
as having changed for better or for worse by their illness 
or its' treatment methods. The mediating factors that act as 
buffers against psychological distress and how the patient's 
social environment affects and is affected by illness needs 
further study (Dakof & Mendelsohn, 1984).
In order for nurses to assist patients and family 
members to successfully optimize the quality of their life 
experiences, it is critical to understand the impact of this 
illness. Despite the multiple medical problems associated 
with PD, the basic human needs of the patient must be met 
effectively if a successful process of adjustment and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
rehabilitation is to be achieved. The challenge to nursing, 
medicine and pharmacological therapy is to sustain a quality 
of life through moderation of physical symptoms, while 
maintaining and sustaining personal and family function and 
relationships which provide support and nurture effective 
adaptive processes.
The mainstay pharmacological treatment for Parkinson's 
Disease is a form of replacement therapy, a levodopa/ 
carbidopa (L-dopa) combination which reduces disease 
symptoms by chemically replacing the neurotransmitter 
dopamine. However, despite pharmacological treatment, a 
steady decline in motor function inevitably ensues. Long 
term therapy with levodopa eventually results in diminished 
efficacy, dose-related motor fluctuations and the 
development of side effects. Though treatment with 
L-dopa decreases mortality and subdues motor symptoms, it 
does not reverse the decline in social functioning (Koller, 
1987) .
Recent interaction studies of levodopa in healthy 
volunteers have suggested that a new medication, tolcapone, 
when given together with levodopa, may result in the need 
for lower doses of levodopa, and provide prolonged efficacy
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of levodopa and potentially fewer side effects. Although 
there exists partially effective drug therapy for the 
symptoms of PD, the length and quality of the PD patient's 
life also depends on the maintenance of social and role 
fulfillment. Patients' quality of life and adaptation are 
clearly affected by both the disease and its treatment 
(Fitzsimmons and Bunting, 1993).
There currently exists an abundance of literature 
describing the effect of pharmacological and surgical 
interventions on motor and depressive symptoms in patients 
with Parkinson's Disease. There is also a large body of 
conceptual nursing knowledge concerning the impact of 
chronic illnesses. However, relatively few investigators 
have dealt with the psychosocial aspects of living with PD. 
Even less attention has been paid to the interaction of 
pharmacological treatment, functional ability, illness 
impact and adjustment (Levin & Weiner, 1987).
For a comprehensive understanding of Parkinson's 
Disease, we need to broaden our perspective on this illness 
to "include the psychosocial aspects which may provide 
buffers against both the physical and psychological 
stressors imposed by chronic illness" (Dakof & Mendelsohn,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1986, p. 3 85). To determine such a perspective includes 
understanding how an individual patient and their family 
experiences and adjusts to their illness. Such a 
comprehensive approach would broaden the perspective on this 
disabling disease to include the critical psychosocial 
component without sacrificing the enormous advantages of the 
biomedical approach (Dakof & Mendelsohn, 1986).
The primary purpose of this study was to determine if 
patients with PD would experience decreased impact of 
illness and improved psychosocial adjustment to their 
illness after treatment with tolcapone. The secondary 
purpose of this study was to reveal the clinical 
significance of subjective non-disease specific indicators, 
quality of life, as critical outcome variables for clinical 
practice and research.
This study was done in parallel with a primary double­
blind placebo-controlled clinical trial which was conducted 
to determine the safety and efficacy of three doses of 
tolcapone when compared to patients receiving a placebo 
(inactive substance).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7
Theoretical Framework 
The theoretical framework supporting this study is the 
cognitive theory of psychological stress and coping of 
Lazarus and Folkman (1984). Coping has long been recognized 
as playing a central role in human adaptation. From this 
theoretical perspective, coping is the process of managing 
demands (external or internal) that are appraised as taxing 
or exceeding the resources of a person. An important 
component of this theory is its focus on process and 
management rather than mastery of demands facing an 
individual. This component is critically important when 
studying chronic illnesses such as Parkinsons1s disease 
which present patients with lifelong problems that can't be 
mastered but can be managed, redefined or tolerated for 
optimal adaptation (Folkman & Lazarus, 1984). This 
perspective is a necessary one for advanced practice nurses 
working in clinical and research practice settings with 
chronic illness populations such as Parkinson's Disease.
From this transactional theoretical view, individuals 
are in dynamic, mutually reciprocal relationships with their 
environment. Such relationships include interactions between 
the individual and other individuals and the institutions
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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representing his or her sociocultural environment. Such 
interactions are usually achieved through loosely prescribed 
behavioral patterns termed roles. The functional 
efficiencies of an individual's role behaviors (e.g., 
spouse, parent, professional) tend to be highly correlated 
with judgments concerning his or her levels of psychosocial 
adjustment (Derogatis & Derogatis, 1990).
Stressful situations which the individual faces, such 
as chronic illness, are appraised as either taxing or 
exceeding one's resources and therefore posing a threat or 
danger to well being. Long term outcomes are moderated by 
two processes: cognitive appraisal and coping.
Cognitive appraisal represents an evaluative process of 
sources of stress as either harm, threat or challenge. The 
appraisal of stressors assists an individual's ability to 
produce a positive outcome or, in the case of Parkinson's 
Disease, to promote optimal adaptation. Lazarus and Launier 
(1978) maintain that the determining feature of response to 
a stressor is the individual's appraisal of the situation.
If individuals are able to cope effectively with the 
problems they face, they may be able to reduce the harmful 
consequences of the stressors (McCrae, 1986) . Coping is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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required to overcome damage or loss, to prevent things from 
getting worse, to come to terms with the situation as it is, 
or to reinterpret the meaning of the stressor.
In this study, the theory of coping and adaptation of 
Lazarus and Folkman was utilized to frame the context of the 
role of the impact of Parkinson's Disease, as a harmful 
stressor, and psychosocial adjustment before and after a 
pharmacological intervention. This theoretical framework 
provides the foundation for examining unique outcome 
measures, illness impact and psychosocial adjustment, in a 
study of a pharmacological intervention. Lazarus and 
Launier's perspective of cognitive appraisal of a stressor 
(such as Parkinson's Disease) as either harm, threat or 
challenge provides support for introduction of the 
subjective patient perspective into a traditionally disease 
oriented approach. Such a theoretical view brings together 
the nursing (person oriented) and medical (disease oriented) 
and research perspectives to develop empirical knowledge 
necessary to aid patients struggling to manage the stresses 
of disabling disease (Lazarus, et al, 1984) .
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Research Hypotheses 
The following hypotheses were tested to determine 
whether the impact of and adaptation to Parkinson's Disease 
is improved after treatment with tolcapone:
1. Total illness impact will be significantly lower in 
individuals with Parkinson's Disease who receive 
tolcapone as compared to patients receiving a placebo 
(inactive substance).
2. Physical illness impact will be significantly lower in 
individuals with Parkinson's Disease who receive 
tolcapone as compared to patients receiving a placebo 
(inactive substance).
3. Psychosocial illness impact will be significantly lower 
in individuals with Parkinson's Disease who receive 
tolcapone as compared to those receiving a placebo 
(inactive substance).
4. Psychosocial adjustment to illness will be 
significantly improved in Parkinson's patients 
receiving tolcapone as compared to those receiving a 
placebo (inactive substance).
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Definition of Terms 
Two major concepts were the focus of this study: impact 
of illness, and psychosocial adjustment to illness. The 
theoretical definitions of these variables were as follows. 
Impact of Illness
The impact of illness is the unique blend of 
psychological and somatic sensations imposed by a chronic 
illness which upsets or stresses people (Haan, 1982). Impact 
of illness was operationalized in this study subjectively by 
the Sickness Impact Profile (SIP) (Bergner 1977) and 
objectively by the Unified Parkinson's Disease Rating Scale 
(Fahn et Elton, 1987).
Psychosocial Adjustment to Illness
Psychosocial adjustment to illness is the quality of a 
patient's psychosocial adjustment to a current medical 
illness or its residual effects. Psychosocial adjustment to 
illness was operationalized by the Psychosocial Adjustment 
to Illness Scale (PAIS-SR) (Derogatis & Derogatis, 1983).
Summayy
Chapter I focused on the concepts of impact of illness 
and psychosocial adjustment to illness as critical 
components in the assessment and treatment of individuals
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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with Parkinson's Disease. Traditionally, emphasis has been 
placed on an objective disease specific focus. The role and 
importance of psychosocial status in overall well being and 
quality of life as a critically important variable for 
measuring outcome in clinical studies and for determining 
clinical improvement has been suggested. The need and 
importance of subjective (patient) measurement of 
improvement in addition to objective determination of 
disease specific measurement has been stressed.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER II 
Review Of The Literature 
Theoretical discourse on the stress-coping-adjustment 
paradigm has been prolific. The existence of the 
relationships between the impact of illness (stress), 
appraisal of illness and coping has been acknowledged in an 
extensive body of literature (Lazarus & Folkman, 1984, 
Folkman, Lazarus, Gruen and De Longis, 1986). However, since 
the generalizability of the entire paradigm to the patient 
with Parkinson's Disease has yet to be confirmed, this study 
focused primarily on the illness impact, cognitive 
appraisal-adjustment relationship. The impact of a chronic 
illness may be even more exaggerated in illnesses which 
result in limitations in movement. Limitations in movement 
have far reaching consequences which considerably effect 
issues of personal independence, role fulfillment, self 
esteem and ultimately psychosocial adjustment. Because the 
symptoms are very obvious in illnesses effecting movement, 
patients often feel stigmatized by their symptoms. Therefore
13
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comparisons with hypertension or heart disease populations 
for example do not provide equal comparison groups. The 
effect of chronic illness and adjustment in diseases with 
limitations in movement, and in Parkinson's Disease in 
specific will be addressed.
The Impact of Illness in Diseases Affecting Movement 
Illness imposes severe, acute, chronic or recurrent 
conditions of psychological stress (Lazarus, 1978). Current 
theory and research on the relationship between stressful 
events and indicators of adaptational status such as somatic 
health and psychological symptoms reflect the belief that 
this relationship is mediated by coping processes (Folkman, 
Lazarus, Gruen and De Longis, 1986).
Several approaches have been used to attempt to 
identify the mechanisms by which the stress-adaptational 
process is mediated. Theoretical approaches have considered 
personality characteristics, the characteristics of the 
stressful situation itself and generalized coping strategies 
applied to all stressful situations.
Though age at diagnosis and disease course varies, 
Rheumatoid Arthritis (RA) and Multiple Sclerosis (MS) 
samples are often compared to patients with Parkinson's
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Disease because of the similar changes in motoric function, 
and the degenerative course of the illness.
Physical health status, personality and interpersonal 
functioning of patients with Multiple Sclerosis were studied 
by Zeldou and Pavlou (1988) . Illness impact measured by the 
Sickness Impact Profile (SIP) was greatest in the physical 
domain (m = 24.6) followed by total impact (m = 21.1) and 
psychosocial impact (m = 17.41). In this study, significant 
differences were found between men and women. Thirteen of 18 
correlations between physical impact scales and 
interpersonal functioning scales were significantly 
different for women compared to 0 of 18 correlations in men. 
However male subjects reported much greater illness impact 
on social interaction (m = 23.20) than females (m = 14.54, t 
= 2.26', p = <. 03) . A significant correlation between age and 
physical illness impact was also found (r = .35, p = c.Ol) 
and total illness impact (r = .30, p = <.01) . Differences by 
sex in this study suggested further opportunity for inquiry. 
The disproportionate sample size of women to men may have 
accounted for these findings, however actual differences in 
illness impact may exist by gender.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The role of illness impact, coping responses, and 
degree of disability of 20 Multiple Sclerosis (MS) patients 
was studied by Buelow (1991). Patients rated fatigue and 
uncertainty about the future as most stressful, while 
needing help eating or dressing and visual changes were the 
least stressful. Degree of disability did not appear to 
correlate with stressors (r = .149) . However, a positive 
correlation was found between uncertainty about the future 
and fatalistic coping style (je = .52, p = c.Ol) and a 
negative correlation between depression and optimistic 
coping (r= -.155, p = <.01). Cautious interpretation of 
these findings must be used however as patients were 
hospitalized and possibly felt more secure and less 
stressed. In addition, participants were treated with 
steroids, often associated with feelings of euphoria which 
might have confounded the results.
The possible relationship of two types of stressors, 
life events and illness experience, to three sets of 
attitudes, life satisfaction, self assessed coping and 
satisfaction with treatment was examined in 97 randomly 
selected outpatients with multiple sclerosis (Counte, 
Bielauskas, and Pavlou, 1983). Personal life satisfaction
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
was measured using the Life Satisfaction Index, and coping 
was measured by the MS Adjustment Scales. Life satisfaction 
was related to hospitalization, (f = 11.7, p = c.001), to 
anxiety (f = 22.6, p = c.001), to age (f = 3.8, p = <.001), 
and to life stress (f = 5.9, p = c.001). Negative 
associations of these variables and personal life 
satisfaction accounted for 45% of the explained variance. 
Higher personal life satisfaction scores were thus found 
among patients who were less anxious, younger, those 
experiencing fewer stressors and had fewer hospitalizations. 
These findings reflected a sample of MS patients with less 
disease severity and disease duration which might account 
for these findings.
To characterize the impact of rheumatoid arthritis (RA) 
in terms of physical and psychosocial changes, Deyo, Inui, 
Leininger and Overman (1982) studied seventy-nine patients 
in four functional categories of RA. Participants completed 
the Sickness Impact Profile (SIP) to determine the impact of 
their disease on physical and psychosocial functioning. When 
compared with 624 individuals from a large pre-paid health 
plan, RA patients had greater mean illness impact (Total SIP 
scores) 15.6 when compared to health plan member controls
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3.6. The SIP physical and psychosocial dimension scores were 
reported to be positively correlated (£ = .478, p = <.001) 
in this study. The authors interpreted these correlations to 
mean that at.a given point in time, a decrease in physical 
function is accompanied by altered psychosocial status. 
However, since these are subscales of the same instrument, 
and are calculated together to determine overall illness 
impact, correlations would be expected and may not 
necessarily be interpreted as concomitant indicators of 
physical and psychosocial change indicative of illness at a 
given point in time. This criticism would seem to be 
appropriate when authors report of the relationship of SIP 
scores to functional categories of American Rheumatism 
Association (disease severity) was examined. Overall SIP and 
Physical Dimension subscale scores increased with increased 
disease severity, however, psychosocial dimension scores 
increased mildly from class 1 to 2 (less disease severity), 
but decreased in class 3 (mild disease severity), while in 
class 4 scores (moderate disease severity) psychosocial 
function remained the same as it had in class 2 disease 
severity. These findings suggested that a linear
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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relationship may not have existed between psychosocial 
function and increasing disease severity in this sample.
The Impact of Parkinson's Disease 
A phenomenologic study of six patients with PD by Marr 
(1991) revealed 4 major themes of the illness: a) impact of 
disease (also described as loss), b) dealing with the 
disease (social interaction losses), c) maintaining 
independence, and d) effort. Though the study sample is 
small, it provided qualitative support for the concept of 
disease impact in the lives of individuals with PD.
A study to examine the effects of levodopa on activity, 
social participation, depression and enjoyment of life was 
performed by Singer (1976) soon after the discovery of 
levodopa therapy. Singer studied 169 patients, 149 before 9 
months treatment with levodopa and 20 who served as 
controls. Singer concluded that levodopa therapy did not 
reverse but rather conserved the decline in social 
functioning, considered a corollary of PD. After treatment 
with levodopa, symptom improvement and others expectations, 
(p = .246, p = <. 05) , (r; = .217, p = <. 05) were significantly 
related to enjoyment of life respectfully. Social 
participation was related to symptom improvement, (r = .224,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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£ = <.05), disease severity,(r = -.308, p = c.Ol), disease 
duration (r; = .25, p = c.Ol) and sick role attitudes, (jr = 
.30, ^ = c.Ol) . Overall, only 2 of 15 variables 
significantly contributed to post-treatment effect. The 
author suggested symptom improvement resulting from 
treatment with levodopa appeared to be independent of 
patients1 initial level of social and psychological 
functioning. Unfortunately this study does not clarify the 
specific operationalization of the sociopsychological 
variables in terms of measurement, validity, reliability or 
evaluative properties. Findings therefore, may not have met 
measurement standards for evaluative properties.
Starkstein, Mayberg, Preziosi and Robinson (1992) 
studied the relationship of depression, cognitive decline 
and impairment in functional ADL in a sample of 105 
individuals with PD. Patients were grouped on the basis of 
psychiatric evaluation into major, minor or no depression 
categories. The patients with major depression showed a 
significantly greater cognitive decline (£ = 4.36, p = c.05) 
and deterioration in functional ADL (£ = 3.26, p = c.05) 
than either the minor or non-depressed group.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
21
The impact of chronic illness was studied in 145 PD 
patients, 735 ET (Essential Tremor) patients and 87 age 
matched community controls by Busenbark, Nash, Hubble and 
Roller (1991). The SIP was used to compare the impact of 
illness related dysfunction in these samples. Patients with 
Parkinson's Disease had much higher illness impact scores 
(total SIP 19.0) when compared to patients with Essential 
Tremor (9.2) and controls (3.4). Similar findings were 
reported in both the physical and psychosocial dimension 
scores. Psychosocial scores were higher in PD patients 
(20.2), when compared to controls (3.6), and in essential 
tremor patients (11.7). Physical dimension scores were 
similarly highest in PD (17.7), control (2.3), and essential 
tremor (9.2). When Parkinson's Disease patients were 
compared with essential tremor and controls, total score, 
dimension scores and subscale scores were all significantly 
different ranging from p = <.0001 to <.05.
In a preliminary study of 12 PD patients and their 
spouses, PD patients' impact of illness correlated 
significantly (r = .41 p <.01) with duration of illness and 
disease stage (r = 0.42, p = <.02) when compared with
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controls who had no significant correlations (Kurlan,
Barold, Page, Como & Shoulson 1989).
Longstreth, Nelson, Linde and Munoz (1992), studied 44 
patients with PD and 44 age and sex-matched controls to 
determine the utility of the SIP in PD. The SIP (total 
score) correlated with the Hoehn and Yahr (r = .59, p =
<.001) and the Columbia Scale (£ = .54, p =.001) .
Significant differences were found between the PD and 
control groups on the SIP (16.8, p = c.001), physical 
dimension (r = 12.9, p c.005) and psychosocial dimension (r 
= 19.4, p = c.001). The authors concluded that the SIP could 
be used to supplement PD-specific disability scales to 
provide a broad measure of functional status in PD as well 
as a promise of documentation of functional changes that 
occur with treatment.
In exploring the relationships between aspects of 
physical illness (clinical severity, Hoehn and Yahr and 
functional disability) 13 6 Parkinsons patients were studied 
by MacCarthy and Brown (1989). Self-esteem, coping style and 
practical support contributed significantly to the variance 
in psychological adjustment. The authors concluded that 
well-being in patients with Parkinson's is not exclusively
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dependent on a simple relationship between disability and 
depression and that other factors should be taken into 
account in the clinical management of the illness.
A controlled trial of piracetam in the treatment of 
intellectually impaired patients with Parkinson's Disease 
was conducted by Sano, Stern, Marder and Mayeux, (1990) . The 
SIP was used to assess functional status in these patients 
and was completed by a family member living with the study 
patient. The authors reported a significant improvement in 
the SIP (total) score in the piracetam group compared with 
the placebo group (p <.05).
The stress of chronic illness in conditions affecting 
movement and PD in particular was illustrated by the studies 
presented. Patients with PD consistently reported both 
physical and psychosocial stress from their illness. Only 
the studies of Sano et al.(1990) and Singer (1976) were 
evaluative, all other studies were discriminative in nature.
Psychosocial Adjustment to Chronic Illness 
Increasing numbers of individuals surviving longer with 
chronic illnesses have shifted the focus of interest from 
mortality to long term morbidity. The demands made by such 
illnesses on the coping skills, psychological integrity, and
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social supports of these patients has brought the 
significance of psychosocial adjustment into bold relief 
(Derogatis & Derogatis, 1990).
A general model of appraisal, coping and adjustment in 
patients with rheumatoid arthritis (RA) was developed by 
Smith and Wallston (1992) . Based on the theory of Lazarus 
and Folkman, a causal model was used to test the short and 
long term adaptation consequences of coping as well as the 
antecedent variables (appraisals, beliefs, social support, 
and disease activity) that promote particular coping styles. 
They concluded that interventions designed to bolster a 
generalized sense of competence and to discourage 
helplessness appraisals and passive coping strategies in 
response to pain, have the potential to improve the 
psychological adjustment and functional well being of 
individuals facing chronic illness.
Cassileth, Lusk, Strouse, Miller, Brown, Cross and 
Tenaglia (1984) studied 758 chronically ill individuals and 
concluded that adaptation to chronic illness was independent 
of a particular diagnosis. In the six diagnostically 
different groups studied no statistically significant 
differences in psychological status emerged. However
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patients whose ambulation was affected had lower scores on 
the dependent variable Mental Health Index (MHI scores). 
Although this study seemed to suggest that diagnostic 
category and severity of disease are independent of 
adaptation, the populations studied may not have been 
comparable when impairment of motor function is more 
carefully considered.
Felton, Revenson and Hinricksen (1984) studied 170 
patients with diabetes, rheumatoid arthritis, arthritis, 
cancer and hypertension. Using a stress-coping model, they 
investigated adjustment among the chronically ill using six 
different coping strategies. Neither level of disability nor 
any other distinction among illnesses played a role in 
determining which coping strategies were effective in 
promoting adjustment to illness. However, responses to open- 
ended questions by patients with cancer and rheumatoid 
arthritis suggested that illness related disabilities did 
affect psychosocial adjustment. These qualitative findings 
suggested that possibly quantitative instruments may not 
have been sensitive to disease impact and disability.
Psychosocial adjustment to illness and its relationship 
to type and severity of illness, cognitive appraisal
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(meaning of illness) and family function were studied by 
Arpin, Fitch, Browne and Corey (1990). In a study of 216 
oncology, rheumatology and gastroenterology patients, the 
cognitive appraisal or meaning variables exceeded the 
importance of all other variables in explaining 14% of a 
person's adjustment to illness. While 70% of this sample 
reported good adjustment to illness, degree of disability 
was positively related to perception of disability 
(b = 5.80). These findings may have reflected a sampling 
bias in this study in favor of patients with minimal 
limitation in physical functioning as only the patients with 
oncology diagnoses appeared to have relatively chronic 
conditions.
Pollock, (1986) investigated physiological and 
psychological adaptation to chronic illness while 
hypothesizing that individuals with a hardiness 
characteristic would have more adaptive behavior than 
individuals without the characteristic. Studying individuals 
with rheumatoid arthritis, diabetes and hypertension,
Pollock found that presence of the hardiness characteristic 
was significantly correlated (r = .43) with physiological 
adaptation and (r = .62) with psychosocial adaptation in the
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diabetic group but not for the hypertensive or rheumatoid 
arthritic groups. Generalizations about chronic illness in 
this study could not be made when recognizing that 
differences in etiology, symptoms and treatment may present 
diverse stressors for patients' adaptive abilities.
Physiological and psychological adaptation to chronic 
illness was studied using the Adaptation model in 211 
patients (Pollock, Christian and Sands 1990) . The 
personality characteristic of hardiness was the only 
variable significantly related to both psychological (r = 
-.13, p = <.05) and physiologic (r = -.16, p = c.Ol) 
adaptation. Physiological adaptation was significantly 
different among three chronic illness categories (rheumatoid 
arthritis, multiple sclerosis and hypertension). Findings 
suggested that physiologic adaptation may be disease 
specific and multi-variable comparisons may leave many 
questions unanswered.
The influence of physical health status, stressful life 
events and various moderator variable on psychosocial 
adjustment in a chronically ill (MS) population was studied 
by Zeldow and Pavlou (1984). Physical dysfunction as 
measured by the SIP had a pervasive influence on personal
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and interpersonal functioning. Mean physical impact scores 
were higher (24.6) than psychosocial impact scores (17.4) 
and overall impact 21.1 falling in the middle. Using 
combined indicators of personality and psychosocial 
adjustment, the authors concluded that greater physical 
disability is associated with decrements in personal 
efficiency and well-being, adaptive autonomy, self-reliance, 
social confidence and actual social contacts.
Examination of the relationship of stress appraisal and 
coping responses to multiple behavioral indices of illness 
adjustment among 101 patients with diverse chronic 
conditions was studied by Bombardier, D'Amico and Jordan 
(1990) . Variables studied included functional impairment, 
depression, symptom severity and coping. Patients indicated 
greater psychosocial dysfunction (29.2) than physical impact 
(17.6) as rated by the SIP. Using regression analysis, 
emotion-focused coping was positively related to poor 
psychosocial adjustment (r = .28) and depression (r = .29) 
after controlling for rated disease severity. Appraisal of 
illness as limiting one's ability predicted greater emotion- 
focused coping responses (r = .38) and poorer adjustment to 
illness. Use of negative coping strategies predicted
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negative adjustment. Illness stress and functional 
impairment were measured by the SIP. The authors concluded 
that specific types of illness appraisal and coping 
responses were concurrent predictors of illness-related 
adaptive functioning, depression and, to a lesser extent 
perceived symptom severity.
A longitudinal study of 103 individuals with multiple 
sclerosis (M.S.) looked at self concept measurement 
differences (t2-tl) as an indicator of adjustment to disease 
(Brooks and Matson, 1982). No change was found in patient 
self concept over time was found during this study. However 
when compared to a non-M.S. comparison group, the study 
group had a small but significantly different change in self 
concept (t-3.09 (p <.01). In this study, change in mobility 
(disease severity) did not correlate significantly with 
change in self concept.
A 1994 review of research on psychosocial adjustment to 
neuromuscular disorders by Liveenh & Antonak, confirms the 
paucity of research in this area specific to individuals 
with PD. The authors conclude that numerous clinical and 
empirical investigations have studied the occurrence and 
nature of depression among people with Parkinson's Disease,
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however little research has been directed at exploring other 
psychosocial reactions to this disease (Livneh & Antonak, 
1994) .
Patterns of adaptation to PD were studied in 44 
patients by Dakof and Mendelshon (1989). Patients 
participated in interviews and completed the Symptom 
Checklist 90. A Q-sort technique was used to analyze the 
interview data. Four clusters of adaptation evolved; 
sanguine and engaged (Cluster I), depressed and apprehensive 
(Cluster II), depressed, ashamed and misunderstood (Cluster 
III) and passive and resigned (Cluster IV). Disease 
severity, but not demographic or other health variables, 
discriminated the groups. Patients with mild to moderate 
impairment adjusted effectively to their illness (Cluster 
I). Clusters III and IV seemed primarily a function of 
physical condition.
Summary
The literature discussed here supports the assumption 
that chronic illnesses act as life stressors and that coping 
may be a mediator in overall adjustment. The relationship of 
disease severity to adjustment and the role of disease 
impact as a stressor warrants further study. Studies in
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movement related diagnoses and in PD in specific revealed a 
variety of interpretations of this relationship. Diversity 
in the selection of variables and in their 
operationalization limits comparison to PD. A majority of 
studies provided support for the existence of considerable 
psychosocial impact from PD and from other movement related 
diseases. The studies reviewed highlight the need and 
importance of disease specific reliable and valid 
instruments in clinical studies.
The majority of studies were discriminative in nature 
rather than evaluative. However, cross-sectional data limits 
the applicability of findings especially where degenerative 
neurologic diseases are concerned. The need for evaluative 
studies is critical to understanding the impact of illness 
overtime, the effect of interventions and their relationship 
to overall adjustment.
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CHAPTER III 
Methodology
Chapter III describes the research design, sample, 
instrumentation, data collection and analysis procedures 
which were used in this study.
Research Design 
This study was done in parallel with a primary double 
blind placebo controlled pharmaceutical clinical trial which 
was conducted to determine the safety and efficacy of three 
doses of tolcapone when compared to placebo (inactive 
substance) for the treatment of individuals with Parkinson's 
Disease. A nonequivalent control group (naturally assembled, 
ambulatory out-patients) design was used for the both 
studies (Campbell & Stanley, 1963). The focus of this 
parallel study was to determine if patients participating in 
the primary study who were treated with tolcapone 
experienced improved psychosocial adjustment to illness and 
experienced less impact of illness (PD) than patients 
treated with placebo.
32
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Using the criteria detailed by Campbell and Stanley 
(1963), the study's design was analyzed for threats to 
internal and external validity. Internal validity is the 
basic minimum without which any experiment is 
uninterpretable: did in fact the experimental treatment make 
a difference? In this study all eight threats to internal 
validity, history, maturation, testing, instrumentation, 
regression, selection, mortality and interation of 
selection, maturation etc. were controlled by the 
experimental design. The process of random assignment 
controlled for the threats to representativeness or 
achieving pre-treatment equality of groups. External 
validity asks the question of generalizability. Lack of 
random selection and the small sample size in this study 
limited the generalizability of the findings.
Sample
The target population was composed of individuals 
diagnosed with idiopathic Parkinson's Disease being seen at 
an outpatient movement disorder clinic. Only individuals who 
met the inclusion and exclusion criteria for participation 
in the primary study were invited to participate in this 
study (see appendix A).
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Participants for this study included a sample of 46 
individuals with idiopathic Parkinson's Disease who met the 
criteria for participation in the primary study. There were 
a total of 49 sets of responses (pre and post treatment 
questionnaires) with 46 final usable data sets.
The final total study sample was comprised of 19 
females (41%) and 27 (59%) males with a mean age of 64 
(range 40-79). Of the 46 subjects, 5(12%) were employed and 
41 (87%) were retired. The majority or 43 (90%) were 
married. A total of 2 (6%) were divorced or separated and 1 
(4%) was widowed. Educational level reflected a mean of 13 
years of education. Eleven (23%) had high school educations, 
18 (34%) had graduated from college and 10 (21%) had 
received graduate or professional education. The mean 
duration of PD was 10.25 years (range of 2.3 to 20.3) .
Random assignment to treatment groups was determined 
and conducted prior to the first patient enrollment by the 
sponsor of the primary study. Dose-related treatment groups 
were utilized to meet sampling needs for the primary study. 
Homogeneity across groups was confirmed prior to data 
analyses and is discussed in Chapter 4. Demographic 
characteristics of the subjects by treatment group are
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illustrated in Table 1. Under blinded conditions, ten 
patients each were assigned to the 50 and 400mg groups, 12 
to the 200mg group and 14 to the placebo group. Age across 
treatment groups ranged from a low of 62 in the placebo 
group to a high of 67 in the 400mg group. Duration of PD was 
lowest in the placebo group, 8 years, to a high of 12 in the 
50mg group. Unified Parkinson's Disease Rating Scale (UPDRS) 
score for motor function ranged from a low of 32 in the 
400mg group to a high of 39 in the 50mg group. A total UPDRS 
score low of 37 was noted in the 400mg group to a high of 47 
in the placebo group. Disease staging as measured by the 
Hoehn/Yahr was the same, 2, across all treatment groups.
Projective statistical techniques were used to 
determine what size samples would be needed to detect the 
same changes as were found in this study. These calculations 
suggested that if all participants in the multi-center study 
(n = 152) had participated in this study, significant 
differences at the p = .05 level might have been detected.
Despite the advantages provided by the experimental 
design, the findings of this study are limited because of 
the small sample size. The samples for each treatment group 
did not reach those projected by the a-priori power analysis
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Table 1




n 14 10 12 10
Age 62 64 64 67
PD Duration 8 12 9 11
Motor UPDRS* 38 39 35 32
Total UPDRS* 47 46 45 37
Hoehn/Yahr* 2 2 2 2
*Disease severity determinant
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calculations. This limits the findings from three 
perspectives: a) small treatment group sizes minimize the 
possibility for detection of significant differences between 
groups and b) limits the generalizability of the study's 
overall findings and c) the possibility of variability in 
such small cell sizes could obscure any real differences 
between groups.
Instrumentation 
The following sections describe the instruments used in 
the study. Representative items from each data collection 
instrument are presented in the Appendices.
Sickness Impact Profile (SIP)
The Sickness Impact Profile (see Appendix B) is 
composed of 136 items describing specific health related 
dysfunction behaviors. Respondents check only items 
describing dysfunction due to their illness. The purpose of 
the instrument is to provide a behaviorally-based measure of 
health status or illness impact (Bergner, 1977). The SIP 
results reflect a subject's perception of performance of 
those activities associated with daily life activities. The 
instrument is composed of two dimensions, physical (3 
subscales) and psychosocial (4 subscales), and five
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independent categories for a total of 12 subscales. In this 
study the SIP results were computed using an overall 
total illness impact score, (the sum of all subscales), a 
physical dimension score (the sum of the ambulation, 
mobility and body care and movement subscales), a 
psychosocial dimension score (the sum of the emotional 
behavior, social interaction, alertness and communication 
subscales), and 5 individual independent category scores 
(the work, sleep and rest, eating, home management and 
recreation and pastimes subscales).
The SIP has been tested extensively in many diagnostic 
categories for test-rest reliability (x = 0.92) and internal 
consistency reliability (x = 0.94). Results are well above 
the .80 acceptable limit for interviewer-administered and 
self-administered instruments (Nunnally, 1978). Convergent 
and discriminant validity have been evaluated using the 
multi-trait multi-method techniques. A summary of the 
multitrait-multimethod correlations of overall scores of the 
SIP with the SAD (self-assessment of dysfunction), SAS (self 
assessment of sickness), and the NHIS (National Health 
Interview Survey Index of Activity Limitation) were 0.92, 
0.82, 0.86 and 0.85 respectively (Bergner, 1981).
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A cross sectional study by Longstreth et al. (1992) was 
performed to determine the utility of the SIP with PD 
patients. The overall SIP score, the physical dimension and 
psychosocial dimensions were significantly correlated (p 
<.001) with the gold standard PD disability measures (Hoehn 
and Yahr [see Appendix E] and the Columbia Scale).
In this study the SIP Cronbach's alpha coefficient was 
0.89 for the entire instrument. Subscale alpha's ranged from 
0.86 to 0.87. Prior to the experimental, intervention the 
SIP total score correlated with the disability measures 
(baseline motor UPDRS score), (x = .45, p = .001), and with 
the total UPDRS (r = .55, p = .0001). The SIP also was 
correlated with the Hoehn and Yahr (r = .42, p = .003) .
These findings were similar to Longstreth1s (1992) 
suggesting a relationship between motor function and disease 
severity.
Psychosocial Adjustment to Illness-SR (PAIS-SR)
The PAIS-SR (see appendix C) is a self report 
instrument designed to assess the quality of a patient's 
psychosocial adjustment to a current medical illness 
(Derogatis, 1978). This 46 item Likert type instrument has 
been used extensively in psychological, sociological and
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clinical medical settings (Derogatis,1990). The seven 
subscales of the PAIS-SR were developed through a 
combination of rational-deductive and empirical-analytic 
techniques. Internal consistency testing of the PAIS-SR was 
assessed in three chronic illness populations: dialysis, 
lung cancer and cardiac patients. Cronbach's alpha 
coefficients for the dialysis population ranged from 0.63- 
0.80, in the cancer patients the range was from 0.12-0.93 
and in the cardiac population from 0.47 to 0.85. The 
subscale which included the item with the .12 score has been 
revised.
Construct validation and principal components analysis 
provided support for the seven theorized dimensions using a 
cancer cohort of 120 patients. The PAIS-SR was tested for 
convergent validity in comparison with four like measures of 
psychological distress: the Affect Balance Scale (ABS), SCL- 
90-R General Severity Index, and the Patient's Attitudes, 
Information and Expectancies Scale (PAIE). PAIS-SR total 
score correlated with the GAIS (x = .81), SCL-90 (r. = .60), 
ABS (r = .69) and PAIE (£ = .64).
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Internal consistency estimations for the PAIS-SR in 
this study were 0.80 for the total instrument with subscale 
alphas ranging from 0.75 to 0.81.
Unified Parkinson's Disease Rating Scale (UPDRS)
The UPDRS (see Appendix D) is a clinical evaluation 
method commonly used by movement disorder specialists to 
objectively assess an individuals symptoms of Parkinson's 
Disease (Fahn & Elton, 1987). The instrument contains three 
dimensions: 1) mood, 2) ADL (activities of daily living), 
and 3) motor. In this study the motor UPDRS scores were 
used. The motor score reported is in the "off" condition. 
This score was determined by physical examination on day 1 
(prior to) and on day 42, at the conclusion of treatment 
with tolcapone (endpoint). The "off" condition is defined as 
motor function without the benefit of levodopa treatment and 
is considered the best approximation of improvement over 
time. Sample items from the UPDRS appear in Appendix B. 
Reliability and validity were not published at the time of 
development, however a post hoc assessment was performed by 
van Hilten, van der Zwan, Zwinderman and Roos, 1994. 
Reliability estimates of 0.88 for the total score and 
concurrent validity of r = 0.75 when compared with the Hoehn
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and Yahr were reported (van Hilten, van der Zwan,
Zwindermkan and Roos, 1994). The UPDRS is considered the 
"gold standard" by movement disorder specialist for 
determining motor function in individuals with PD in 
clinical and research settings.
Hoehn and Yahr
The Hoehn and Yahr (see Appendix E) is a 5 point scale 
used to categorize a patient's disease stage. Hoehn and Yahr 
data were collected in order to analyze subgroup differences 
by disease stage and to determine if patients disease stage 
was acceptable for initial eligibility for the primary 
study.
Demographic Questionnaire
An investigator-developed demographic questionnaire was 
used to collect representative demographic data (see 
Appendix F). These data were used to describe the sample as 
well as to allow for analysis of specific subsets within the 
sample and potential correlations with outcome variables. 
Representative demographic data included age, sex, 
education, marital status, and number of years with PD.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
Data Collection 
Approval to conduct the research was obtained from the 
Research Committee at the University-affiliated movement 
disorder clinic where patients were recruited, and from the 
Committee for the Protection of Human Subjects (CPHS) at the 
University of San Diego (see Appendix G). After permission 
was obtained from the appropriate institutions, chart 
abstraction was used to gather information to determine 
preliminary subject eligibility. Patients meeting the 
criteria for inclusion were approached to determine their 
interest in participation (see Appendix A). Individuals 
received a complete explanation of the project including 
assurance of confidentiality and anonymity. Individuals who 
agreed to participate, provided informed consent and who met 
the inclusion and exclusion criteria were scheduled for a 
preliminary screening visit.
Qualified and consenting subjects came to the clinic 
for disease severity determination and rating of motor 
symptoms by a physician specially trained in movement 
disorders. Patients who met the primary study inclusion 
criteria and who provided informed consent were approached 
for participation in the nursing study. At the screening
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visit for the primary study, all participants had a complete 
physical and neurologic exam, safety laboratory tests, an 
EKG, and urinalysis. Participants were also instructed in 
how to complete a diary of their Parkinson symptoms. 
Participants whose screening exams were normal returned in 2 
weeks for a baseline visit for the primary study. At the 
baseline visit, all nursing study participants completed the 
nursing study instrument packet, prior to beginning 
treatment with the investigational medication. Participants 
began treatment on the day following the baseline visit with 
one of the three double blind doses of study medication or 
placebo. Participant experimental group assignment had been 
pre-randomized by the primary study sponsor. Study 
participants were followed over six required primary study 
visits for safety and monitoring purposes. On the final 
visit of the primary study, day 42, all nursing study 
participants completed a second set of nursing study 
instruments identical to those completed at the baseline 
visit.
Data Analysis
Descriptive statistics were used to characterize the 
sample and distribution characteristics. Measures of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
45
variability were calculated on the control and treatment 
groups to determine the homogeneity of the treatment groups 
in order to meet statistical test assumptions. Non- 
parametric statistical techniques were used for comparison 
of subgroup distributions within the sample because of the 
nominal level of the data (Kerlinger, 1989) .
Pearson's Product Moment Correlation coefficients were 
calculated to determine relationships between demographic 
and study variables.
The research hypotheses were tested using repeated 
measures analysis of variance and planned comparisons 
(Munro, Visantainer & Page, 198 6). Assumption requirements 
of homogeneity of variance, equality of covariance matrices 
and compound symmetry were satisfied prior to analyses. 
Following preliminary hypothesis testing, further post-hoc 
analysis were performed where indicated.
The statistical tests were selected based on the 
assumptions of homogeneity of variance (the groups should 
have equal variances), mutual exclusivity (the groups are 
independent of each other) and compound symmetry. There are 
two components of compound symmetry; the correlations across 
the measurements are the same, and that the variances should
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be equal across measurements (Munro et al., 1986). The 
assumptions of the repeated measures analysis of variance 
were all met prior to the analyses.
Summary
This chapter has detailed the methods used in the 
study. An experimental design was used to test the 
hypotheses in this study. It was hypothesized that impact of 
illness and psychosocial adjustment would improve after 
treatment with tolcapone. A naturally existing sample of 
individuals with idiopathic Parkinson's Disease were 
randomly assigned to one of four treatment conditions of a 
double-blind placebo controlled primary study of tolcapone. 
Repeated measures analysis of variance was used to test 
hypotheses posed for this study. Post-hoc analysis was also 
performed to insure treatment group homogeneity.
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CHAPTER IV 
RESULTS
Study findings are presented in this chapter. The 
chapter includes the following sections: 1) data reduction, 
2) determination of homogeneity of treatment groups, 3) 
hypothesis testing, and 4) post-hoc analyses.
Data Reduction 
Data reduction was accomplished through a plan of data 
cleaning. Prior to data entry procedures, all study 
instruments were scrutinized for missing data and 
unacceptable data which were defined as data out of range of 
study variable limits. Initially 49 sets or partial sets 
(pre and post questionnaires) were considered for inclusion. 
Following extensive cleaning and data verification, 46 
complete sets of data were used for analysis with the SIP, 
PAIS-SR, demographic data and functional status 
measurements.
47
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Determination of Homogeneity of Treatment Groups 
Homogeneity of treatment groups was determined using 
analysis of variance procedures on all demographic and 
treatment variables. In this double blind design, all 
subjects received treatment (placebo included), therefore 
all groups were included in analyses. No significant 
differences were found between demographic or treatment 
variables when comparisons by treatment group were examined. 
Post-hoc analyses using Scheffe's test and Bonferroni (Dunn) 
T tests confirmed that no significant differences existed 
between members of any of the treatment groups (Munro, 
Visantainter & Page, 1986).
Hypotheses Testing 
Repeated measures analysis of variance planned 
comparisons were performed to test the study hypotheses. 
Tests of the assumptions of multivariate normality, equality 
of covariance and compound symmetry were met for each of the 
hypotheses prior to performing the analyses (Munro et al., 
1986). Table 2 summarizes the results of hypotheses testing. 
Using repeated measures analyses, significant differences 
were detected when combined dose-related treatment groups 
were compared to the placebo group for each of the three
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Table 2
Results of Hypotheses Testincr
SS DF MS F P
Illness Impact 303.138 1 303.138 10.024 < . 003
1207.071 42 30 .240
Physical Impact 246.279 1 246 .279 10.958 < . 002
943.922 42 22 .474
Psychosocial 349.042 1 349.042 8.177 <.007
Impact 1792.042 42 42.684
Adjustment 9758.970 1 9758.970 2.356 <.132
173972.828 42 4142.210
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illness impact hypotheses. These groups were conbined due to 
the small number of subjects per group, and to specifically 
test the hypotheses generated for the study.
Hypothesis 1 . Patients receiving tolcapone experienced 
significantly less total illness impact (p. = <.003) when 
compared to patients receiving placebo.
Hypothesis 2 . Patients receiving tolcapone experienced 
significantly less physical illness impact (p = <.002) when 
compared to patients receiving placebo.
Hypothesis 3 . Patients receiving tolcapone experienced 
significantly less psychosocial illness impact (p= <.007) 
when compared to patients receiving placebo.
Hypothesis 4 . Psychosocial adjustment to illness was 
improved in all patients after treatment with tolcapone but 
did not differ significantly from patients receiving a 
placebo.
Post-Hoc Analyses
Individual variable score change from baseline to week 
six (day 42) was used to compute the differences in SIP and 
PAIS-SR scores for subjects in the placebo group and 
treatment groups.
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Post-hoc analyses were performed to determine if any 
significant pairwise comparisons of individual treatment 
groups could be found. When the changes in scores from 
baseline to endpoint were compared no significant 
differences were found. However, when the percent change was 
tested using a Bonferroi (Dunn) T, a significant (p = <.05) 
change from baseline to endpoint was found between the 200mg 
tolcapone and placebo groups.
Though the changes in illness impact and psychosocial 
adjustment from baseline to endpoint were not statistically 
different by individual treatment group, the importance in 
the changes noted may be more clinically than statistically 
relevant. Figures 1, 2, and 3 illustrate the changes found 
in illness impact. The importance of clinical significance 
is discussed in Chapter 5.
Reductions in illness impact were found in all three 
tolcapone dose treatment groups in total illness impact 
(SIP) scores, physical dimension scores and psychosocial 
dimension scores. In contrast, patients in the placebo group 
reported increases (worsening) in illness impact over the 
same 6 week period. Table 3 illiistrates the pre- to post­
scores . Though none of these changes were found to be
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Dose Related Illness Impact Pre/Post Treatment
Tolcapone
Placebo 50mg 200mg 400mg
n 14 10 12 10
Pre Post Pre Post Pre Post Pre Post
Total SIP 16.8 18.0 17.0 13 .7 19.1 14 . 6 15.9 10.2
Physical 11.6 13 .2 15.0 9.7 15.1 13.5 10.8 6.1
Psychosocial 17.5 18.7 14.9 12.4 18.0 11.4 16.0 10 .7
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statistically significant by treatment group, all of the 
treatment groups reported they experienced less clinical 
illness impact. Similarly in all of the tolcapone treatment 
groups, the 12 individual category scores of illness impact 
(total scores) patients reported improvement (lowering of 
illness impact scores) in all categories with the exception 
of 2. In the 50mg tolcapone group no change was reported 
(0.0) between baseline and 6 weeks. Similarly, the 200mg 
tolcapone group reported a 2.2 change (worsening) in 
mobility from baseline to week 6.
In the placebo group 8 category scores increased 
(worsening of illness impact) while 3 reported improving and 
1 score with no change (0.0) . Patients receiving placebo 
reported a (-0.2) change in emotional behavior, a (-5.2) 
change in communication, and a (-6.8) change in recreation. 
The raw change and percent change scores are illustrated in 
Table 4.
Similarly, though no significant differences were found 
in psychosocial adjustment to illness, many dose related 
response improvements were observed in a subscale analyses 
of the PAIS-SR. In the total sample post-treatment 
improvement was found in a majority of the subscales and in
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Table 4
Illness Impact Change From Baseline to Endpoint
Placebo 50mg 200mg 40 0mg
Score Change 
Raw (%)
Illness Impact +1.2 (7%) -3.3 (20%) -4.5 (23%) -5.7 (36%)
Physical +1.5(13%) -5.4 (36%) -1.6(11%) -4.6 (43%)
Psychosocial +1.2 (7%) -2 .6 (17%) -6.6(37%) -5.4 (34%)
Adjustment -.6(<1%) -16(5%) -12(3%) -20 (6%)
UPDRS motor +0.8(2%) -1.1(2%) -3.5 (8%) -3.2 (8%)
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the PAIS-SR total score (Table 5). In the 200mg Tolcapone 
group, all subscale and total scores were improved. In the 
50mg and 4 00mg groups, small negative changes (+.1 and +.2) 
were found respectfully in the extended family relationship 
subscale. The 50mg group also reported a (+.5) worsening in 
psychological distress. In contrast the placebo group 
reported psychosocial adjustment worsened in the sexual 
relationship (+1.28) and social environment (+.61) 
subscales. However, placebo patients reported improvement in 
orientation to healthcare environment (-.43), vocational 
environment (-.57), domestic environment (-.93) and extended 
family relationships (-.14). Total PAIS-SR scores improved 
by (-.64). Though many of the improvements in illness impact 
and psychosocial adjustment were not statistically 
significant, the importance of these findings appeared to be 
in the realm of clinical significance.
At baseline, indicators of association were found 
between the impact of illness (SIP) and disease severtiy. 
Similar correlations were not found between the PAIS-SR and 
disease severity. Table 6 describes the associations found 
at baseline and correlations of change found at endpoint.
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Table 5
Dose Related Psychosocial Adjustment Responses
Placebo 50mg 200mg 400mg
n 14 10 12 10
Pre Post Pre Post Pre Post Pre Post
HCSUB 6.0 -5.6 4.9 3.7 7.0 6.1 5.1 3.4
VESUB 6.4 -5.1 7.4 6.2 5.6 2.9 5.5 5.2
DESUB 7.6 -6.7 7.2 5.3 7.9 7.3 4 . 9 4.5
FRSUB 2.4 -2.5 1.2 1.3 3.0 2.4 .9 1.1
SRSUB 4.3 5.0 3.1 3.1 5.8 5.1 5.4 5.1
SESUB 6.9 7.5 7.6 6.2 6.8 6.5 5.3 3 . 8
PDSUB 5.3 5.7 6.4 6.9 6.0 4.6 8.0 5.9
RAW 357 356 354 337 364 352 345 325
HCSUB-Healthcare orientation VESUB-Vocational Environment 
DESUB-Domestic environment FRSUB-Extended Family Relationship 
SRSUB-Sexual Relaitonships SESUB-Social Environment 
PDSUB-Psychological Distress RAW- Total Adjustment Score





UPDRS Total Motor UPDRS Hoehn
Post
Pre Post Pre Post Pre
SIP TOTAL .55***
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At endpoint, minimal correlations of change were found 
between disease severity and illness impact (£ = .25, p =
< . 08), and SIP psychosocial dimension (£ = .26, p = <.08) 
suggesting the relationship between disease severity and 
illness impact may have been independent of the treatment.
Summary
This chapter has summarized the methods used to 
accomplish data reduction and confirm homogeneity of 
treatment groups. Correlations between demographic and study 
variables and hypotheses testing and results were discussed. 
The impact of illness was lessened in individuals treated 
with tolcapone. When compared with improvement in motor 
function, illness impact percent change appeared to be more 
responsive to treatment. Psychosocial adjustment though 
improved in individuals treated with tolcapone appeared to 
be a less robust response than illness impact.
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CHAPTER V 
DISCUSSION AND RECOMMENDATIONS 
This chapter presents a discussion of the findings of 
the study, the strengths and limitations of the study, and 
recommendations for future research. The study's findings 
are compared and contrasted to previous research reported in 
the literature.
Illness Impact
The patient's perspective of the impact of Parkinson's 
Disease on overall quality of life has been a major focus of 
this study. Illness impact emerged as the most robust 
variable. Pre to post treatment changes in total ii^ess 
impact, physical impact and psychosocial impact scores 
primarily followed a treatment response pattern (placebo 
patients worsened, and treatment patients improved) over the 
length of the study.
Baseline illness impact scores for toter ;j^a.ct, 
physical impact and psychosocial .impq.̂ ’ ••^“■e (17.29).
(13.10) and (16.78) respect fariv* - These werA somewhat
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different from those of Busenbark et al.'s (1991)study of PD 
patients. Busenbark's (1991) sample appeared to experience 
more illness impact than this sample with total scores of 
(19.0), physical dimension scores of (17.1), and 
psychosocial dimension scores of (20.2). In contrast, Zeldow 
and Pavlou's (1988) MS sample had higher physical impact 
scores, (22.3)lower psychosocial impact scores, (14.0) and 
more similar in total impact (19.2) when compared to this 
study sample. Deyo et al.'s (1982) study of Rheumatoid 
Arthritis (RA) patients rated total impact (15.6), physical 
impact (14.0) and psychosocial impact (11.3) indicating the 
RA patients felt less illness impact than the PD patients in 
this study.
Sano et al. (1990), in a study of PD dementia, reported 
the only evaluative use of the variable of illness impact in 
a movement disorder related sample. They reported 
significantly (p <.05) more subjects categorized as improved 
on the SIP score in the treatment group compared to the 
placebo group however no actual data for this conclusion was 
published (Sano et al.,1990). Significant improvement was 
reported in the drug treatment group compared to the placebo 
group on the rating of recreation and pastime. Again no
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actual data were published. The present study's findings had 
similarities to those reported by Sano, et al. (1990). Total 
illness impact improved across all treatment groups when 
compared to the placebo, as did the recreation and pastime 
subscale scores in the three treatment arms. However, in 
this study, the recreation and pastime subscale in the 
placebo group actually reported improvement by (+ 6.75) .
Such a change can only be accounted for by a "placebo" 
effect since all of the other placebo group scores increased 
(worsened) during the study, with the exception of very 
small changes in the emotional behavior subscale (10.66 pre, 
10.46 post) and work subscale (43.16 pre and 43.13 post). 
Comparisons with Sano et al.'s (1990) study must be done 
with caution. Raw data were not reported and therefore 
actual comparisons of methods/analysis could not be done 
with precision.
When comparing the published SIP scores of related 
samples, and of studies with PD patients, the PD sample in 
this study appeared to be consistent with existing 
literature with respect to the variability in disease 
severity among individuals with PD. The motor scores of 
patients in this study were compared on the basis of the
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worst "off" of the day (approximately 8-10 hours without 
medication). All patients were evaluated under the same 
conditions in order to control for between patient 
variability. This element of control is not usually found in 
cross-sectional studies and therefore provides a higher 
level of precision of measurement.
Disease Severity and Illness Impact
The relationship between disease severity and illness 
impact was explored using bivariate correlations. Ratings of 
disease severity at baseline (UPDRS total and motor and 
Hoehn and Yahr) indicated that all three measures were 
associated with many components of illness impact. Since 
Parkinson's Disease is progressive in nature, disease 
staging indicators (Hoehn and Yahr) could be expected to be 
associated with indicators of illness stress. This study's 
findings like those of Zeldow & Pavlou (1988) revealed that 
severity of illness (not duration) was a more influential 
determinant of a patients perception of impact of illness. 
Duration of PD was only mildly correlated with emotional 
behavior and home management.
The findings of this study were similar to those of 
Brown and MacCarthy's study of PD who found significant
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associations of illness stress and patient self report of 
best/worst disease severity (£ = .54, p = <.001, s. = .52, p 
= <.001).
In contrast, in Kurlan et al.'s study (1989) the SIP 
total correlated significantly (r = .32, p <0.5) with age 
and more closely with duration of PD (r = .41 p = <.01) and 
Hoehn/Yahr (r = 0.42, p = <0.2). Comparable findings in this 
study support Kurlans1 data on the relationship of disease 
severity and the SIP total (motor UPDRS and Hoehn/Yahr both 
significantly correlated (p = <.001 and p = <.003) 
respectfully. However they differ in that age did not 
correlate with illness impact in this study as it did in 
Kurlan, et al.'s (1989) study.
Busenbark, et al.'s (1991) study published no data of 
correlations of SIP with disease severity, however they did 
report that PD patients scored significantly higher than ET 
patients in total SIP, physical dimension and psychosocial 
dimension scores.
In this study, the change in motor UPDRS (from baseline 
to endpoint) was only mildly correlated with the change in 
SIP total (r = .26, p = <.09) and the change in SIP 
psychosocial score (£ =.26, p = <.08) . These findings
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suggested that although motor function was improved by 
treatment with tolcapone, the changes in illness impact 
appeared to be independent of changes in motor function. 
Psychosocial Adjustment and Disease Severity
At baseline, disease severity was not as strongly 
associated with psychosocial adjustment as was impact of 
illness. Motor UPDRS was associated with only 2 PAIS 
subscales, domestic environment (r = 25, p = <.09) and 
sexual relationships (x = -43, p = <.003). Total UPDRS was 
associated with the same subscales domestic environment (x = 
.33, p = 0.02) and sexual relationships (x = .45, p =
<.002) . In addition there was also an association with 
social environment (x = -30, p = <.04). The psychological 
distress subscale and PAIS-SR total score were related to 
duration of PD, motor UPDRS at baseline, total UPDRS at 
baseline and Hoehn/Yahr. Duration of PD at baseline was not 
correlated with any of the subscale or total PAIS-SR 
measures. These findings are similar to those of MacCarthy 
and Brown, (1989) whose adjustment measure of depression was 
associated with disease severity (x = .37, p = <.001 and 
acceptance of illness (x= -55, p = <.001). Functional 
disability (as measured by ADL) proved to be the index which
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best predicted depression in MacCarthy's study of PD 
patient's.
These findings supported those of previous studies 
(MacCarthy & Brown, 1989, Viney & Westbrook, 1984) which 
suggested that adjustment to chronic illness may be more 
closely related to appraisal of illness and intervening 
variables than disease severity or duration alone. Larger 
evaluative studies of PD such as this one, would aid in 
clarifying these preliminary findings.
Illness Impact and Psychosocial Adjustment
The impact of illness as a stressor in Parkinson's 
Disease has been supported by this study's findings.
All three hypotheses of the effect of tolcapone on 
decreasing illness impact were supported. The relationship 
of decreased illness impact as a contributor to psychosocial 
adjustment remains unclear. The relationship of change in 
illness impact and change in psychosocial adjustment is also 
unclear. The significant change over time of selected 
illness impact variables and their association with 
adjustment suggests the need for future studies with larger 
samples sizes and similar control measures. Change in 
psychosocial adjustment was associated with change in SIP
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total score (r = .25, p = <.ll). This nonsignificant 
association only mildly supports the relationship found at 
baseline (p = .72, p = <.0001). Further studies are needed 
to fully understand the nature of this relationship.
Clinical Significance
Previous evaluative studies in PD have primarily 
focused on physiologic or disease state outcome measures.
The importance of these studies rests more on clinical 
significance. Physiologic or disease state measurement 
provides information to clinicians but are of limited 
interest to patients and may often correlate poorly with 
functional capactiy or perceived well being (Guyatt, Feeny,
& Patrick, 1993). The key to clinical significance lies in 
interpretability, whether a particular change in score 
represents a trivial, small but important, moderate or large 
improvement, or deterioration.
In this study, changes in illness impact and disease 
state were standardized into percent change scores in order 
to enhance interpretability. Using statistical techniques 
(t-tests) only 1 of 20 pairwise comparison's were 
significant (total illness impact in the 400mg group 
compared to placebo). However, using the standardized
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percent change comparisons, nine of nine illness impact by 
treatment group comparisons showed improvment (11% to 43%). 
In comparison the traditional disease severity percent 
changes showed improvement however considerably smaller than 
the quality of life variables (2% to 8%). Such differences 
suggested that traditional disease severity assessments, 
however informative for treatment considerations, may not 
correlate well with patients perception of functional 
capacity or well being.
Implications and Recommendations 
The importance of subjective patient centered 
measurement of disease symptoms and experience has yet to be 
recognized in all areas of neuroscience practice. Findings 
from studies such as this highlight the need for 
incorporation of this critical component into clinical 
practice.
The evaluative methods used in this study provide a new 
level of knowledge compared to previous cross sectional 
studies. Interpretation and application of findings must be 
cautious, however, because of the small sample size. However 
power analysis estimation using the treatment differences 
found in this study, project that significant differences at
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the .05 and .03 levels could be detected if this study were 
replicated with larger sample size studies. Despite the 
importance of generalizability of findings, it should not be 
overlooked that, when examining differences in clinical 
status and function, the importance of small if not 
significant changes should be considered.
In the out patient setting, improvement and change is 
often measured objectively, by the clinician. Determination 
of improvement may be based not on significant benefit from 
therapy, but by lack of adverse effects or deterioration 
from a previous assessment. Previous studies have examined 
disease state alone without inclusion of subjective or 
quality of life outcome measures. The importance of 
subjective outcome measures is particularly important when 
considering outcome in the geriatric age group such as 
Parkinson's disease. Elderly patients often suffer from 
ongoing disabilities which confound their illness 
experience.
It is obvious that quality of life can be significantly 
affected by PD and the drugs employed to treat it (Roller, 
1994). A concern has been raised that these (quality of 
life) instruments may not have the sensitivity to detect
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changes in quality of life compared with the more 
traditional measures of clinical status (Koller, 1994). Two 
important points should be raised: quality of life measures 
may include functional (disease status) components, but are 
not limited to this focus. Psychometrically sound, disease 
specific QOL instruments may prove to be equally sensitive 
to traditional measures considering the subjective nature of 
their source. The disabilities resulting from PD are not 
limited to manifestations of motor function alone. Sleep 
disturbances, sexual dysfunction, mental status changes are 
but a few examples of disability which may be related to the 
disease or from drug therapy and are overlooked in 
traditional disease focused measurements.
The findings of this study support just such a 
possibility. In the case of illness impact, 9 of 9 variables 
had greater percent change improvement than the "gold 
standard" UPDRS. Illness impact change (improvement) after 
treatment with tolcapone ranged from 11% improvement to 43% 
improvement, compared with 2% to 8% improvement in motor 
UPDRS score. In the case of psychosocial adjustment, 
improvement ranged from 0% to 33% (see Table 4). Such 
changes highlight the importance of measurement of quality
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of life in evaluative studies of PD. Clearly these findings 
suggest that patients perceive the impact of their illness 
in many areas besides motoric function.
The importance of utilizing research findings as a 
basis for future studies is critical. This study illustrates 
the importance of evaluative clinical studies which include 
prior research findings in addition to traditional measures. 
Maintaining a narrowly focused view on disease 
symptomatology and indicators, forgoes the rich 
possibilities of utilizing subject based studies.
One of the most important implications of this study is 
recognition of the necessity of including quality of life 
assessment into routine clinical practice. As the shift of 
health care delivery moves into the out-patient and home 
setting, nurses will be called upon to assist patients and 
their families to adapt to the stressors of chronic illness. 
Though this study has utilized formal research measurement 
techniques, these same instruments may be used in clinical 
practice situations as assessment techniques at intake, for 
follow-up over time, or for determining change or 
improvement with treatment. Determining change in functional 
status in chronic illness situations often presents the
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clinician with a challenge in trying to quantify change. Use 
of quality of life measurement will augment assessment with 
additional and enriched data for determining a plan of care.
Summary
Using repeated measures analysis of variance 
techniques, this study provided new information on the 
impact of chronic illness and its1 treatment in adjustment 
to Parkinson's Disease. In addition, it sheds light on the 
role and relationship of pharmacological treatment in 
quality of life for patients with Parkinson's Disease.
Health care outcomes will increasingly be measured from 
the patients point of view. Benefits of treatments and the 
overall health care system will be judged in terms of the 
extent to which changes in the patient's functioning or well 
being meet his/her needs and expectations (Ware, 1992).
The shift in health care delivery, and the focus on the 
patient rather than disease systems will bring nursing into 
new partnerships in health care delivery. Focusing on the 
patient (as a whole entity) is not a new revelation to 
nursing practice. However, the moment must be seized. 
Increasing routine nursing assessments to include a broader 
functional status component will allow for evaluation in
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terms of impact on patient functioning and well being in 
addition to traditionally defined endpoints.
Assisting patients and their families to live 
successfully, to adapt and cope with the long term effects 
of chronic illness such as Parkinson's Disease will be a 
challenge of the future. Nursing has the opportunity to 
contribute to the delivery of outpatient care, by utilizing 
research findings such as these to improve the overall 
quality of patient's lives.
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APPENDIX A
INCLUSION/EXCLUSION CRITERIA OF DOUBLE-BLIND STUDY
Inclusion Criteria:
1. Onset of PD at age 3 0 or older.
2. Male or female (surgically sterile or amenorrheic for 
one year).
3. Patients with predictable ON response to the first 
daily dose of Sinemet.
4. Patients taking three doses of Sinemet/day, 1:4 ratio, 
stable for at least one month, with four off periods
not including the first off on arising.
5. Patients must be able to complete diaries recording,
on, off medication times and demonstrating four or more 
off periods in 10 hours.
6. Patient must be compliant at least 90% during the 
placebo baseline period.
7. Patients must sign a written informed consent.
Exclusion Criteria:
1. Patients with atypical Parkinsonian variations.
2. Patients with unpredictable motor fluctuations.
3. Patients with a history of cerebral insult sufficient
to cause delayed secondary Parkinsonism.











Patients with drug-induced Parkinsonism.
Patients with a Hoehn and Yahr stage 4 Or 5 when ON. 
Patients with resting tremor as the sole manifestation 
of Parkinson's Disease.
Patients with dyskinesias that are severely or 
completely disabling.
Patients with clinically significant hepatic, renal, 
cardiovascular, endocrinologic, respiratory, neurologic 
or gastrointestinal disorders, or other current medical 
problems that may place them at increased risk. This 
includes people with clinically significant laboratory, 
vital sign or ECG abnormalities.
Patients with psychotic illnesses, chronic psychiatric 
disorders, drug or alcohol dependence.
Patients with intellectual impairment as determined by 
a score of 25 or less on the Mini-Mental status. 
Patients treated within the preceding six months with 
dopamine antagonists.
Patients treated within the preceding two months with a 
MAO inhibitor.
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13. Patients treatment within the preceding one month with 
peripheral dopamine antagonists or any investigational 
drug.
14. Patients treated within the preceding one month with 
psychoactive drugs.
15. Patients who are taking indocin, anticoagulants, 
antidiabetics, phenytoin, pheylbutazone.
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APPENDIX B 
SICKNESS IMPACT PROFILE 
BODY CARE AND MOVEMENT SUBSCALE
Sample Items:
1. I do not maintain balance.
2. I stay lying down most of the time.
3. I do not bathe myself completely, for example, require 
asistance with bathing.
4. I have trouble getting shoes, socks, or stockings on.
5. I stand only for short periods of time.
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APPENDIX C
PSYCHOSOCIAL ADJUSTMENT TO ILLNESS- SELF REPORT 
SEXUAL FUNCTIONING SUBSCALE
Sample Items;
1. Sometimes when people are ill they report a loss of 
interest in sexual activities. Have you experienced 
less sexual interest since your illness?
a) absolutely no sexual interest since illness
b) a marked loss of sexual interest
c) a slight loss of sexual interest
d) no loss of sexual interest
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APPENDIX D 
UNIFIED PARKINSON'S DISEASE RATING SCALE 
Sample i.t,em:
1. Tremor at rest
0 = absent
1 = slight and infrequently present
2 = mild in amplitude and present most of the time
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APPENDIX E
HOEHN AND YAHR 
DISEASE SEVERITY RATING











HOEHN AND YAHR 
DISEASE SEVERITY RATING
no signs of PD
unilateral involvement only-
unilateral and axial involvement
bilateral involvement without
impairment of balance
mild bilateral involvement with
recovery on retropulsion




Severe disability, still able to 
walk or stand unassisted 
Wheelchair bound or bedridden 
unless aided.
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APPENDIX F 
DEMOGRAPHIC QUESTIONNAIRE






1. Sex: Female  Male____
2. Date of Birth:____________
3. Marital Status: Single_ Married_________
Divorced/Separated_ Widowed________
4. Year Parkinson's Disease was Diagnosed:____________
5. Education: (Circle Highest Year Completed)
Elementary thru High School 1 2 3 4 5 6 7 8 9  10 11 12 
College 13 14 15 16 Graduate 17
6. Presently Employed  Retired  Seeking Work____
PATIENT: PLEASE LEAVE QUESTIONS BELOW BLANK
Hoehn and Yahr: "ON"__________  "OFF"_
Total Motor UPDRS: Pre Post
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